| Measles, mumps, and rubella. | |
| | |
MedLine Citation:
|
PMID: 22510638 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Measles, mumps, and rubella are viral diseases that may adversely affect nonimmune pregnant women and their fetuses/neonates. Prevention of these diseases and their complications can be achieved through measles-mumps-rubella (MMR) vaccination before pregnancy. The vaccine is contraindicated during pregnancy, because it contains live, attenuated viruses that pose a theoretical risk to the fetus. However, accidental receipt of MMR vaccination is not known to cause maternal/fetal complications. MMR immunization is recommended to nonimmune obstetric patients upon completion or termination of pregnancy. |
| | |
Authors:
|
Sarah J White; Kristi L Boldt; Sara J Holditch; Gregory A Poland; Robert M Jacobson |
Related Documents
:
|
22592078 - Effect of a dna vaccine harboring two copies of inhibin α (1-32) fragments on immune r... 22913258 - Hiv epidemic in asia: optimizing and expanding vaccine development. 22786948 - The impact of a novel franchise clinic network on access to medicines and vaccinations ... 22318278 - Immunogenicity and tolerability of recombinant serogroup b meningococcal vaccine admini... 12900048 - Novel vaccine strategies with protein antigens of streptococcus pneumoniae. 21336758 - Early experiences with nasal vaccines against meningococcal disease. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Clinical obstetrics and gynecology Volume: 55 ISSN: 1532-5520 ISO Abbreviation: Clin Obstet Gynecol Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-04-18 Completed Date: 2012-09-25 Revised Date: 2013-02-19 |
Medline Journal Info:
|
Nlm Unique ID: 0070014 Medline TA: Clin Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 550-9 Citation Subset: IM |
Affiliation:
|
Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, Minnesota, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Female Health Promotion Humans Immunoglobulins / therapeutic use Immunologic Factors / therapeutic use Infectious Disease Transmission, Vertical / prevention & control Measles / complications, diagnosis, drug therapy, epidemiology, prevention & control* Measles-Mumps-Rubella Vaccine / administration & dosage*, contraindications Mumps / complications, diagnosis, epidemiology, prevention & control* Pregnancy Pregnancy Complications, Infectious / etiology, prevention & control* Rubella / diagnosis, epidemiology, prevention & control* Vulnerable Populations |
| Grant Support | |
ID/Acronym/Agency:
|
R01 AI033144/AI/NIAID NIH HHS; R01 AI033144-15/AI/NIAID NIH HHS; R01 AI33144-15/AI/NIAID NIH HHS; R01 AI48973-11,/AI/NIAID NIH HHS; R37 AI048793/AI/NIAID NIH HHS; R37 AI048793-11/AI/NIAID NIH HHS; UL1 RR024150-01/RR/NCRR NIH HHS; UL1 RR024150-01/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Immunoglobulins; 0/Immunologic Factors; 0/Measles-Mumps-Rubella Vaccine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hepatitis B: treatment to prevent perinatal transmission.
Next Document: Varicella-zoster virus: prevention through vaccination.